OKYO Pharma Limited Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019
OKYO Pharma Limited (OKYO) reported Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 of $1.54 per share for the 12-month period ending 2025-03-31, per its 20-F filed 2025-07-18.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 · last filed 2025-07-18
| Period end | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 12 month | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 12 month as first filed |
|---|---|---|
| 2025-03-31 | $1.54 20-F · filed 2025-07-18 | |
| 2024-03-31 | $1.53 20-F · filed 2025-07-18 | |
| 2023-03-31 | $1.04 20-F · filed 2025-07-18 | $1.61 20-F · filed 2023-08-15 |
| 2022-03-31 | $5.46 20-F · filed 2024-08-13 | $8.41 20-F · filed 2022-08-15 |
| 2021-03-31 | $7.31 20-F · filed 2023-08-15 |